New England Biolabs, Inc.

Ipswich, MA ManufacturingNAICS 325100

Self-funded health planPlan year 2025Renews March
630Participants+14% vs. prior year
$1.5MEst. pharmacy spend / yrParticipants × national avg.
Mar 2027Next renewalPlan year begins March 1
#41 of 48Manufacturing in MABy participants

Overview

New England Biolabs, Inc. sponsors a self-funded health plan that covered 630 participants in plan year 2025, up 14% from the prior year. The plan year starts in March. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
630 · prior year 553
Plan year
Begins March 1 · next renewal March 2027
Health plans filed
New England Biolabs, Inc. Group Health and Welfare Plan, plan 503 (630 participants)
Broker compensation
$69K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Unum Life Insurance Company of AmericaLife, Long-term disability, Long Term Care1,136$326K$56K
Prudential Insurance Company of AmericaLife, Long-term disability549$172K$7K
Eyemed Vision Care on Behalf of Fidelity Security Life Insurance Co.Vision791$55K$5K
KGA, Inc.Employee Assistance Program589$18K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$1.5M/ year

Estimated prescription spend: 630 participants × $2,371 national average per member. Usually higher once dependents are counted.

$39K–$96K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$11K–$28K
Lower-cost therapeutic alternatives$17K–$35K
Generic pricing vs. actual cost$7K–$22K
PBM contract terms$4K–$11K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning March 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
New England Biolabs, Inc.
Sponsor EIN
04-2631963
Plan number
503
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 04-2631963 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: New England Biolabs, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with New England Biolabs, Inc..

Request a correction · Methodology